• Frank Solis, Andres Plasencia, Sarah Wahlster, Melanie Walker, Michael R Levitt, and Rosa Ecos.
• Neurological Surgery and Endovascular Neurosurgery, Clínica Internacional San Borja, Lima, Peru; Endovascular Neurosurgery Unit, Instituto Nacional de Ciencias Neurológicas, Lima, Peru. Electronic address: endovascularsolis@gmail.com.
• World Neurosurg. 2023 Dec 1; 180: 798579-85.

BackgroundStenting with flow diverter devices (FDDs) has increasingly emerged as a treatment for intracranial aneurysms. The use of FDDs in the developing world has not been described.MethodsA retrospective review was performed of a cohort of patients who underwent flow diversion at 4 tertiary-care centers in Lima, Peru between January 2017 and June 2021. Demographics, clinical features, and aneurysm morphology were evaluated. Clinical outcomes were observed 3 months after discharge and occlusion rates were assessed 12 months after treatment.ResultsSixty-nine patients (mean age, 46 ±14.5 years; 17% female) were treated with FDDs; 4% (n = 3) of the treated aneurysms were ruptured. Most aneurysms were saccular (n = 65; 94%), <10 mm in maximum size (n = 60; 87%), and located in the anterior circulation (n = 67; 97%). Minor complications, such as groin hematoma, occurred in 7 cases. No serious complications or deaths occurred. Patients' functional status was excellent (modified Rankin Scale score 0-1) in 99% (n = 66) at discharge and 100% (n = 67) at 3 months. Although some patients were lost to follow-up, complete occlusion was seen in 76% (n = 31) of 41 treated patients at 12 months.ConclusionsWe report the largest multicenter experience of FDDs for cerebral aneurysm treatment in Peru, with reasonable outcomes that are comparable to other settings despite various challenges, suboptimal circumstances, and lack of resources.Copyright © 2023 Elsevier Inc. All rights reserved.

22 keywords...

hide…